Download PDF
1 / Pages

Other users also viewed these articles

Sofosbuvir-based regimens for HCV in stage 4¿stage 5 chronic kidney disease. A systematic review with meta-analysis Fabrizio Fabrizi; Roberta Cerutti; Vivek Dixit; Ezequiel Ridruejo;
Nefrologia (English Version). 2021;41:578-89
The impact of antiviral therapy for HCV on kidney disease: a systematic review and meta-analysis Fabrizio Fabrizi; Roberta Cerutti; Vivek Dixit; Piergiorgio Messa;
Nefrologia (English Version). 2020;40:299-310
Hepatitis B virus vaccine and chronic kidney disease. The advances Fabrizio Fabrizi; Roberta Cerutti; Vivek Dixit; Ezequiel Ridruejo;
Nefrologia (English Version). 2021;41:115-22